These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15203289

  • 1. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
    Zobel AW, Schulze-Rauschenbach S, von Widdern OC, Metten M, Freymann N, Grasmäder K, Pfeiffer U, Schnell S, Wagner M, Maier W.
    J Psychiatr Res; 2004; 38(4):377-83. PubMed ID: 15203289
    [Abstract] [Full Text] [Related]

  • 2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 3. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L.
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [Abstract] [Full Text] [Related]

  • 4. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 5. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
    Bschor T, Ising M, Erbe S, Winkelmann P, Ritter D, Uhr M, Lewitzka U.
    J Psychiatr Res; 2012 Jan; 46(1):111-7. PubMed ID: 22030468
    [Abstract] [Full Text] [Related]

  • 6. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C.
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [Abstract] [Full Text] [Related]

  • 7. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 8. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr 01; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S, Dose T, Wollweber B, Spieler D, Messer T, Lutz R, Künzel H, Bierner T, Pollmächer T, Pfister H, Nickel T, Sonntag A, Uhr M, Ising M, Holsboer F, Lucae S.
    J Psychiatr Res; 2009 Jan 01; 43(3):215-29. PubMed ID: 18586274
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 01; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 11. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M.
    Neuropsychobiology; 2007 Feb 01; 55(1):28-35. PubMed ID: 17556850
    [Abstract] [Full Text] [Related]

  • 12. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
    Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M.
    Biol Psychiatry; 2007 Sep 01; 62(5):400-6. PubMed ID: 17188252
    [Abstract] [Full Text] [Related]

  • 13. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V, Dinan TG, Scott L, Corcoran C.
    Biol Psychiatry; 2005 Dec 15; 58(12):963-8. PubMed ID: 16005439
    [Abstract] [Full Text] [Related]

  • 14. Direct and dam-mediated effects of prenatal dexamethasone on emotionality, cognition and HPA axis in adult Wistar rats.
    Hauser J, Feldon J, Pryce CR.
    Horm Behav; 2009 Oct 15; 56(4):364-75. PubMed ID: 19616002
    [Abstract] [Full Text] [Related]

  • 15. HPA axis activation in major depression and response to fluoxetine: a pilot study.
    Young EA, Altemus M, Lopez JF, Kocsis JH, Schatzberg AF, DeBattista C, Zubieta JK.
    Psychoneuroendocrinology; 2004 Oct 15; 29(9):1198-204. PubMed ID: 15219644
    [Abstract] [Full Text] [Related]

  • 16. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun 15; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 17. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov 15; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 18. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B.
    Pol J Pharmacol; 2002 Nov 15; 54(4):343-9. PubMed ID: 12523487
    [Abstract] [Full Text] [Related]

  • 19. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
    Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
    [Abstract] [Full Text] [Related]

  • 20. Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response.
    Hatzinger M, Hemmeter UM, Brand S, Ising M, Holsboer-Trachsler E.
    J Psychiatr Res; 2004 Aug 15; 38(5):453-65. PubMed ID: 15380395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.